Ledger.Open graph →
SEC Form D · filed September 13, 2019

Cidara Therapeutics, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Kurt Graves · Boston, MADirectorCorey M. Steffek · Boston, MAExec · DirectorGino Santini · Boston, MAExecPepe Zevada · AUSTIN, TXExecRobert Levine · FARMINGTON HILLS, MIExecPaul Feldman · Boston, MADirectorThane Wettig · Boston, MADirectorKim Bishop · Grand Cayman, Cayman IslandsDirectorKeith Crandell · Boston, MAExec · DirectorMarc Lehmann · Miami Beach, FLExecIan Charles · FARMINGTON HILLS, MIDirectorThomas L. Croft · DARTMOUTH, Nova Scotia, CanadaDirectorCameron W. Mcrae · Dartmouth, Nova Scotia, CanadaDirectorAndrew Funk · Denver, COExecRobert L. Whitham · Shenandoah, IAExecMichael D. Weiss · New York City, NYDirectorDavid R. Gollaher · San Diego, CADirectorJessica R. Oien · San Diego, CAExecJames R. Levine · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗